Background. Lung volume reduction operations have been shown to improve the
quality of life and functional status of some patients with end-stage emph
ysema.
Methods. Because of a perceived increase in the occurrence of postoperative
gastrointestinal (GI) complications, we reviewed our experience in 287 pat
ients who had lung volume reduction operations to determine the frequency o
f GI complications and to identify risk factors.
Results. Using a broad definition of postoperative GI complications (nausea
, vomiting, abdominal distension, gastroesophageal reflux, diarrhea, consti
pation) there were 137 complications in 67 patients (23%). More severe GI c
omplications (bowel ischemia, GI bleeding, perforation, ulceration, ileus,
colitis, cholecystitis, pancreatitis) occurred 49 times in 27 patients (9.4
%). Seven of the 27 patients required abdominal operations. Risk factors id
entified as predictive of severe complications include diabetes (p = 0.0003
), lower preoperative hematocrit (p = 0.01), steroid use (p = 0.02), and us
e of parenteral meperidine analgesic (p = 0.002). Stepwise logistic regress
ion demonstrated that diabetes was 7.02 times more likely to produce severe
complications. Other risk factors included steroids (2.81), number of diff
erent pain medications (2.59), hematocrit decrease of 5% (1.96), and hemato
crit decrease of 1% (1.14). In the patients wit severe GI complications the
re were six of 27 (22%) hospital deaths compared with five of 260 (2%) in t
hose without GI complications (p = 0.0001).
Conclusions. Severe GI complications in patients with emphysema who had lun
g volume reduction operations are not uncommon (9.4%) and influence the per
ioperative mortality rate. Heightened awareness to identified risk factors
will allow earlier recognition, prevention, and perhaps decrease morbidity
and mortality rates in these high-risk patients. (Ann Thorac Surg 1999;68:1
029-33) (C) 1999 by The Society of Thoracic Surgeons.